Bright Minds BiosciencesDRUG 
$1.294.03%24h
4.03%24h
Global rank34200
Market cap$4.80M
Change 7d4.45%
YTD Performance-13.42%
SP500 benchmarkUnderperform
P/E-0.65
P/S0
Revenue$0
Earnings-$5.42M
Dividend yield-
Main Sector
Healthcare
Category
Bright Minds Biosciences (DRUG) Total Liabilities
DRUG Total Liabilities in 2022: $206.63K
According to Bright Minds Biosciences latest financial reports the total liabilities of DRUG is $206.63K, an decrease of -81.82% to 2022. At the end of 2022 company had $1.14M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Bright Minds Biosciences is responsible for during its operational activities.
Bright Minds Biosciences (DRUG) Total Liabilities History from 2023 to 2022
-
Value:-
DRUG Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $206.63K | -81.82% |
| 2022 | $1.14M | 141.86% |
| 2021 | $469.80K | 323.11% |
| 2020 | $111.03K | - |
View the Top Total Liabilies Stocks
